Remove 2000 Remove Clinical Trials Remove Treatment
article thumbnail

Medical Marijuana is Being Used to Treat Dementia With Success

FloridaMarijuana.net

The Dementia Society of America attributes Dementia to rising healthcare costs as billions are spent each year for treatments and research. They estimate that the number of people aged 65 years and older is expected to increase from 35 million in 2000 to 71 million in 2030. million in 2000 to 19.5 million in 2030.

article thumbnail

Knowde Group Inc.™ Enters Into a Strategic Partnership with LMC Manna Research to Drive Quality and Collaboration in the Conduct of Cannabis and Psychedelic Clinical Trials.

Cannabis Law Report

There is an urgent need for objective, scientifically sound and robust clinical trials to support medicinal cannabis and psychedelics (psilocybin, MDMA, LSD, Ketamine). Collectively, between the two organizations we offer a full-service package from protocol development to timely and successful clinical trial execution.”.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A New Treatment: CBD Oil For Autism?

Puff Puff Post

With so many people affected by autism and incidence rates having increased by 119% between the years 2000 to 2010, it has gained the status of the quickest-growing developmental disability. The Current Treatments for Autism. CBD also helps to treat seizures, a common overlap for those with autism. What Exactly is Autism ?

article thumbnail

Dr. Andrew Weil on Cannabis and Integrative Medicine

Project CBD

He is the author of several bestselling books, including Spontaneous Healing (1995), Eating Well for Optimum Health (2000), and Healthy Aging (2007). And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions.

Medicine 308
article thumbnail

Which States Are Voting on Psychedelics?

Veriheal

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Johns Hopkins University first received regulatory approval for psychedelic research in the year 2000. Connecticut Gov. Minnesota Rep.

article thumbnail

U.S. Funding Focuses on Marijuana’s Harms, Not Benefits

CannaMD

research funders, the National Institute on Drug Abuse (NIDA) , spent over $1 billion between 2000 and 2008, with a heavily slanted focus on cannabis abuse and misuse, as well as the negative effects of cannabis. While some funds are being used to study cannabis medical treatments, the majority of funding is still used to research harms.

DEA 105
article thumbnail

Study: Oral CBD Use Has Anxiolytic and Anti-Psychotic Activity

The Joint Blog

This is according to a study published in the Journal of Clinical Medicine Research and epublished by the U.S. For the study researchers with the Nordic Cannabis Research Institute in Denmark reviewed 25 clinical trials assessing the safety and efficacy of CBD in various populations. National Institute of Health.